Largest health care pharmaceutical companies by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 61 health care pharmaceutical companies ranked by total liabilities, at HUF 46.65T, ahead of Pfizer (HUF 41.27T) and Johnson & Johnson (HUF 40.01T). Figures as of 20 Nov 2026, 04:16 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- AbbVieHUF 46.65T
- Median
- HUF 708.6B
- Combined market value
- HUF 1687.24T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | HUF 46.65T | HUF 170.41T | HUF 96,406.44 | 0.86% down | 25% up | ||
| 2 | PfizerPFE · Health Care | HUF 41.27T | HUF 53.37T | HUF 9,363.88 | 1.85% down | 15% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | HUF 40.01T | HUF 218.66T | HUF 90,830.27 | 2.04% down | 34% up | ||
| 4 | Eli LillyLLY · Health Care | HUF 29.22T | HUF 409.2T | HUF 459,394.31 | 2.29% down | 33% up | ||
| 5 | Merck & CoMRK · Health Care | HUF 28.63T | HUF 111.32T | HUF 45,156.73 | 3.61% down | 45% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | HUF 24.32T | HUF 40.55T | HUF 19,836.18 | 2.05% down | 30% up | ||
| 7 | AstraZenecaAZN · Health Care | HUF 22.22T | HUF 92.5T | HUF 59,641.15 | 1.87% down | 1% up | ||
| 8 | NovartisNVS · Health Care | HUF 21.9T | HUF 97.11T | HUF 51,416.31 | 2.57% down | 25% up | ||
| 9 | SanofiSNY · Health Care | HUF 20.78T | HUF 37.61T | HUF 15,660.86 | 2.25% down | 4% down | ||
| 10 | GSKGSK · Health Care | HUF 20.38T | HUF 32.59T | HUF 16,259.28 | 1.56% down | 5% up | ||
| 11 | Novo NordiskNVO · Health Care | HUF 17.6T | HUF 58.25T | HUF 13,216.19 | 1.42% down | 17% down | ||
| 12 | Takeda PharmaceuticalTAK · Health Care | HUF 17.21T | HUF 23.26T | HUF 7,279.61 | 0.66% up | 51% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | HUF 11.54T | HUF 61.17T | HUF 35,316.84 | 0.58% down | 16% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | HUF 11.16T | HUF 15.29T | HUF 13,103.99 | 8.74% down | 74% up | ||
| 15 | ViatrisVTRS · Health Care | HUF 7.64T | HUF 7.75T | HUF 6,759.40 | 1.97% down | 99% up | ||
| 16 | GrifolsGRFS · Health Care | HUF 4.57T | HUF 1.9T | HUF 2,788.08 | 3.19% down | 0% up | ||
| 17 | ZoetisZTS · Health Care | HUF 4.13T | HUF 11.16T | HUF 27,469.41 | 5.59% down | 26% down | ||
| 18 | Royalty PharmaRPRX · Health Care | HUF 3.37T | HUF 13.24T | HUF 23,025.48 | 1.38% down | 79% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | HUF 3.16T | HUF 32.48T | HUF 313,944.83 | 2.35% down | 28% up | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | HUF 2.5T | HUF 5.16T | HUF 80,395.36 | 4.57% down | 41% up | ||
| 21 | GenmabGMAB · Health Care | HUF 2.39T | HUF 10.77T | HUF 17,459.51 | 0.75% up | 70% up | ||
| 22 | Vertex PharmaceuticalsVRTX · Health Care | HUF 2.37T | HUF 44.88T | HUF 177,029.61 | 2.94% down | 27% up | ||
| 23 | Elanco Animal HealthELAN · Health Care | HUF 2.32T | HUF 4.47T | HUF 8,938.86 | 1.54% down | 26% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | HUF 1.42T | HUF 6.73T | HUF 50,260.28 | 1.06% down | 66% down | ||
| 25 | BeOne MedicinesONC · Health Care | HUF 1.3T | HUF 15.52T | HUF 135,902.00 | 0.97% down | 16% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | HUF 1.25T | HUF 2.53T | HUF 7,272.81 | 2.24% down | 90% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | HUF 1.06T | HUF 1.66T | HUF 19,831.08 | 3.16% down | 21% down | ||
| 28 | Ionis PharmaceuticalsIONS · Health Care | HUF 1.03T | HUF 1.54T | HUF 9,255.07 | 0.62% down | 63% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | HUF 1.02T | HUF 5.18T | HUF 26,581.98 | 0.22% up | 21% up | ||
| 30 | Dr. Reddy's LaboratoriesRDY · Health Care | HUF 719.6B | HUF 4.2T | HUF 5,042.35 | 1.00% down | 8% up | ||
| 31 | CytokineticsCYTK · Health Care | HUF 708.6B | HUF 2.44T | HUF 17,496.91 | 0.27% up | 19% down | ||
| 32 | Ascendis PharmaASND · Health Care | HUF 552.8B | HUF 5.71T | HUF 87,028.96 | 5.32% down | 29% up | ||
| 33 | InsmedINSM · Health Care | HUF 518.7B | HUF 10.78T | HUF 49,117.84 | 20.58% up | 40% down | ||
| 34 | BioMarin PharmaceuticalBMRN · Health Care | HUF 512.4B | HUF 4.05T | HUF 20,883.41 | 0.02% down | 17% up | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | HUF 299.8B | HUF 2.1T | HUF 14,841.44 | 1.25% up | 13% up | ||
| 36 | United TherapeuticsUTHR · Health Care | HUF 266.5B | HUF 8.1T | HUF 190,099.59 | 3.16% down | 22% up | ||
| 37 | Legend BiotechLEGN · Health Care | HUF 248.8B | HUF 1.06T | HUF 5,474.16 | 0.92% down | 41% down | ||
| 38 | AlkermesALKS · Health Care | HUF 227B | HUF 2.64T | HUF 15,701.66 | 1.43% down | 66% up | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | HUF 223.4B | HUF 3.13T | HUF 134,895.57 | 0.34% down | 27% down | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | HUF 204.5B | HUF 2.43T | HUF 46,132.56 | 1.25% up | 6% down | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | HUF 184.8B | HUF 1.95T | HUF 97,562.47 | 3.94% down | 50% up | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | HUF 179.6B | HUF 2.12T | HUF 32,474.36 | 3.27% up | 34% up | ||
| 43 | Travere TherapeuticsTVTX · Health Care | HUF 166.7B | HUF 1.58T | HUF 16,422.48 | 3.86% down | 45% up | ||
| 44 | Roivant SciencesROIV · Health Care | HUF 141.5B | HUF 9.6T | HUF 13,246.79 | 0.59% up | 91% up | ||
| 45 | TG TherapeuticsTGTX · Health Care | HUF 141.2B | HUF 3.33T | HUF 22,059.85 | 1.88% down | 117% up | ||
| 46 | Cogent BiosciencesCOGT · Health Care | HUF 102.4B | HUF 1.64T | HUF 9,431.88 | 0.25% down | 20% down | ||
| 47 | Rhythm PharmaceuticalsRYTM · Health Care | HUF 71.5B | HUF 2.75T | HUF 39,713.17 | 1.88% down | 18% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | HUF 66.7B | HUF 2.5T | HUF 31,802.84 | 1.59% down | 129% up | ||
| 49 | Corcept TherapeuticsCORT · Health Care | HUF 64.2B | HUF 2.42T | HUF 22,093.85 | 4.15% down | 10% down | ||
| 50 | ABIVAXABVX · Health Care | HUF 48.7B | HUF 2.4T | HUF 27,421.81 | 3.79% down | 32% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | HUF 36.6B | HUF 1.37T | HUF 10,023.49 | 1.24% up | 168% up | ||
| 52 | Summit TherapeuticsSMMT · Health Care | HUF 31.4B | HUF 2.87T | HUF 3,593.91 | 0.67% up | 36% down | ||
| 53 | ErascaERAS · Health Care | HUF 24.1B | HUF 1.7T | HUF 4,834.94 | 3.34% up | 395% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | HUF 21.3B | HUF 3.15T | HUF 33,195.18 | 3.77% down | 332% up | ||
| 55 | Praxis Precision MedicinesPRAX · Health Care | HUF 20.3B | HUF 2.95T | HUF 105,709.11 | 1.87% up | 86% up | ||
| 56 | Protagonist TherapeuticsPTGX · Health Care | HUF 18.2B | HUF 2.75T | HUF 42,168.04 | 2.47% down | 51% up | ||
| 57 | Dianthus TherapeuticsDNTH · Health Care | HUF 12.8B | HUF 1.62T | HUF 28,843.05 | 1.01% up | 108% up | ||
| 58 | Edgewise TherapeuticsEWTX · Health Care | HUF 10.3B | HUF 1.53T | HUF 13,998.21 | 0.48% down | 86% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | HUF 5.7B | HUF 2.25T | HUF 33,174.78 | 1.91% up | 255% up | ||
| 60 | Belite BioBLTE · Health Care | HUF 3.4B | HUF 2.09T | HUF 51,348.31 | 3.33% down | 43% up | ||
| 61 | VeradermicsMANE · Health Care | HUF 3.1B | HUF 1.78T | HUF 42,293.84 | 0.38% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 340.0 HUF).
Questions and answers
Which health care pharmaceutical companies rank first by total liabilities?
AbbVie (HUF 46.65T), Pfizer (HUF 41.27T) and Johnson & Johnson (HUF 40.01T) are the top three of the 61 health care pharmaceutical companies ranked by total liabilities as of 20 Nov 2026, 04:16 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by total liabilities.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by total liabilities have a combined market value of HUF 1687.24T as of 20 Nov 2026, 04:16 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by total liabilities”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.